To mimic the characteristics of AML blasts, we used an AML mouse model driven by the MLL-AF9 fusion oncogene that results from the t(9;11)(p22;q23) translocation, which is found in AML patients and associated with an intermediate prognosis [30–32]. Here, KMT2A is linked to acute myeloid leukemia.